Objectives On the basis of a systematic review, we aimed to establish the cost and drivers of cost and/or resource use of intra-and perioperative complications occurring as a result of selected major surgical procedures, as well as to understand the relationship between costs and severity of complication and, consequently, the economic burden they represent. We also assessed the clinical and economic methodologies used to derive costs and resource use across the studies with a view to providing guidance on reporting standards for these studies. Methods We searched EMBASE, MEDLINE and Econlit (from 2002 to 2012) for study publications including resource use/cost data relating to surgical complications. Results We identified 38 relevant studies on pancreatic (n = 14), urologic (n = 4), gynaecological (n = 6), thoracic (n = 13) and hepatic surgery (n = 1). All studies showed that complications lead to higher resource use and hospital costs compared with surgical procedures without complications. Costs depend on type of complication and complication severity, and are driven primarily by prolonged hospitalisation. There was considerable heterogeneity between studies with regard to patient populations, outcomes and procedures, as well as a lack of consistency and transparency of reporting of costs/resource use. Complication severity grading systems were used infrequently. Conclusions The overall conclusions of included studies are consistent: complications represent an important economic burden for health care providers. We conclude that more accurate and consistent data collection is required to serve as input for good-quality economic analyses, which in turn can inform hospital decisions on cost-efficient allocation of their limited resources.
Introduction
The cost of health care is increasing around the world, with hospital costs accounting for a considerable proportion of total costs. In Switzerland and France, in 2010, 36 and 34 %, of total health care costs, respectively, were attributable to hospitals [1, 2] . Similarly, in the US, 31 % of total health care costs were attributable to hospitals in 2010 [3] .
As more sophisticated interventions and new treatments become available, there is a high demand from health authorities for evidence of incremental clinical value as well as health economic assessments in order to make use of the limited resources in the most cost effective way. Hence, in order to obtain meaningful data on the cost effectiveness of surgical treatments, reliable data on relevant outcomes and their costs must be collected in a standardised and reproducible manner [4, 5] .
Surgery represents a considerable proportion of hospital services and is generally a costly procedure, requiring considerable resources intraoperatively as well as costly hospital stays. Despite advances in technology, techniques and knowledge, major surgical procedures are still associated with considerable morbidity and mortality. Surgical complications are generally considered to be the most appropriate surrogate outcome for the quality of surgical care [6] [7] [8] . The economic consequences of major surgical complications have been the subject of a number of publications. In cost analysis of major surgery, Vonlanthen et al. [9] observed a dramatic increase in cost with the severity of the complication. Furthermore, complications were the strongest indicator of cost for the hospital. In a study on the cost of lobectomy or pneumonectomy, Handy et al. [10] concluded that complications are associated with increased cost. Several other studies agree in their conclusions that complications are still of high prevalence and cause considerable additional costs (e.g. Yu et al. [11] and Nagel et al. [12] ). However, there has so far been no systematic review on this topic. We performed a systematic review in order to consolidate the available evidence on the burden of intra-and postoperative surgical complications, occurring in 13 commonly performed major procedures, across several surgical segments (gynaecological, hepatopancreaticobiliary, spleen, thoracic and urological procedures). In view of the large amount of available data, we chose to limit our choice of surgical procedures to represent those in which surgical sealants are generally used [13, 14] . Sealants are useful in preventing some complications, such as surgically-induced leakage of air, gastrointestinal contents or body fluids, and may also be haemostatic [15] .
Our objective was to establish the cost and drivers of cost and/or resource use of intra-and perioperative complications occurring as a result of these major procedures, as well as to understand the relationship between costs and severity of complication and, consequently, the economic burden they represent. We also aimed to assess the clinical and economic methodologies used to derive costs and resource use across the studies with a view to providing guidance on reporting standards for these studies.
Methods
This systematic review has been performed in accordance with Cochrane guidelines [16] . We applied the following eligibility criteria: participants were to be aged 18 years or older, who received a specified surgical procedure from 1996 onwards in Europe, the US, Australia, New Zealand or Canada. The surgical procedures included were endometriosis resection, hysterectomy, pelvic lymphadenectomy, hemihepatectomy/major liver resection, pancreaticojejunostomy, left (distal) pancreatectomy, pancreaticoduodenectomy, splenectomy, lung resection, atypical lung resection, mediastinal lymph node dissection, partial nephrectomy and radical prostatectomy. Search terms are listed in detail in the online Appendix (see electronic supplementary material [ESM], Table A1 ) and comprised major complications associated with the major surgical procedures included (e.g. infection, haemorrhage, air/fluid leaks and iatrogenic complications). There were no restrictions as to whether the procedure was performed by open, laparoscopic or robot-assisted laparoscopic techniques. The collected outcomes from the clinical data used to derive resource use or cost data were overall complication incidence, complication incidence according to the Clavien-Dindo classification [5, 17] , incidence of intra-or postoperative complications, grade or intensity of reported complications, incidence of secondary complications (arising from primary complications) and mortality. The Clavien-Dindo classification is a reproducible system that grades complications according to severity: grades I and II do not need/need pharmacological treatment, respectively; grades III and IV require intervention or surgery and intensive care management, respectively; whereas grade V indicates a lethal complication [5, 17] . Resource use outcomes collected included all types of hospital visits and stays, outpatient visits and services, and management of complications. Any direct or indirect costs associated with resource use were included. Eligible studies could be comparative observational studies, randomised controlled trials (RCTs), decision-analytic or cost-prediction models, cost analyses or cost/burden of illness studies.
EMBASE, MEDLINE and Econlit were searched for full publications in English from January 2002 to 19 June 2012 (detailed search strings are available in the online Appendix; see ESM Tables A2-A4) . A combination of Medical Subject Headings (MeSH) and free-text terms on resource use, complications and procedures were used. The abstracts and titles of each citation were independently screened by two researchers (AP and FA). Those that did not match the eligibility criteria were excluded. Agreement on inclusion/exclusion was very high and disputes were referred to a third party (SC) for discussion. Papers included in the first pass were retrieved in full and were screened by hand to identify any relevant studies meeting the inclusion criteria. A pre-determined data extraction table was designed in Microsoft Excel Ò to capture the study methodology, results, and clinical (complication rates reported), resource use and cost outcomes. Any disagreements relating to eligibility or interpretation were resolved by consensus. All costs have been converted to US$ as follows: inflation adjustments (to 13/17 June 2013) were calculated using the free service at http://fxtop.com/ en/inflation-calculator.php, using the suggested countryspecific inflation index. If necessary, costs were then converted to US$ using http://www.xe.com. Conversions were performed on 13 June 2013. These converted values are given in brackets to allow meaningful comparison of costs. Where no cost year was reported, we have used the year of data collection; if a longer time period was reported for data collection, the end of data collection was used.
Results
The search strategy yielded 4,130 citations ( Fig. 1) . After duplicates were removed and after first-pass exclusion, 69 publications remained, which were retrieved as full text. On reapplication of the eligibility criteria, a further 31 studies were excluded, resulting in 38 included publications on pancreatic surgery (14 studies), urologic surgery (4 studies on radical prostatectomy), gynaecological procedures (6 studies on hysterectomy), thoracic surgery (13 studies on lung resection) and hepatectomy (a single liver resection study). The majority of studies (n = 23) were based in North America, with the remaining studies using data from European countries. The number of patients analysed ranged from as few as 28 (in single-hospital studies) to 269,041 (in some database studies). The resource use and costs associated with complications are provided as extracted data in the online Appendix (see ESM; Tables A5-A12). Of the 38 included publications, 26 described the design of their analysis as retrospective (with two of these reported as based on prospectively collected data) and five as prospective. Three publications described themselves as analysis of prospective data, clinical and cost-benefit analysis and cross-sectional analysis, whereas four publications did not report a study design (Table 1) .
Methodological Approaches for Resource Use and Estimating Cost
Across the 38 included studies only payer/hospital (not societal) costs were included (although the perspective is often not reported, this is evident on the basis of the cost description). Generally, costs considered were hospital length of stay (LOS) costs and complication treatment costs. Some cost data were reported in 7/15 hepatopancreaticobiliary studies [18] [19] [20] [21] [22] [23] [24] , 1/4 urology studies [11] , 4/6 gynaecology analyses [25] [26] [27] [28] and 4/13 thoracic studies [10, [29] [30] [31] . Cost analysis was a main objective in five hepatopancreaticobiliary studies [19, 20, [22] [23] [24] . Five publications [18, [21] [22] [23] [24] calculated cost based on hospital accounts. Daskalaki et al. [19] used hospital data and derived hospital costs from a regional list of health care costs, and resource use unit prices from a national list of unit prices. Kent et al. [20] did not give details of their cost data sources. Yu et al. [11] (urology) derived costs from total hospital bills.
As for the analyses on gynaecologic surgery, Gunnarsson et al. [27] quote a reimbursement database as their cost source. Rotermann [28] derived resource use (LOS) from a large Canadian database, and they note that only limited cost information (of re-admissions only) was available from published regional reports on hospital costs. Coello et al. [25] used a database for LOS, deriving additional cost of surgical site infections (SSIs) per bed day from a previous publication (which was then adjusted with the hospital and community health service annual inflation index). De Lissovoy et al. [26] also used a database and converted hospital charges to costs using the Nationwide Inpatient Sample (a US database) cost-to-charge ratio file.
Finally, of the thoracic surgery analyses, both Roselli et al. [30] and Handy et al. [10] used databases, covering data from one and two hospitals, respectively, with Handy et al. further specifying that cost data were obtained from an associated accounting database, using a top-down approach. Pilling et al. [29] used patient records from a single surgeon's practice, estimating cost by the 'weighted hospital days' method [32] , whereas Varela et al. [31] prospectively recorded data from a single hospital, acquiring cost data from the hospital accounting department and the hospital pharmacy.
Resource use was estimated retrospectively in the majority of the included publications, where data were collected from databases or hospital patient records. Prospective resource use data collection is reported for 8/15 hepatopancreaticobiliary studies [18, 19, 21-24, 33, 34 ] and 3/13 thoracic studies [31, 35, 36] . Data sources for resource use are outlined in Table 1 , and were either hospital patient records, or larger databases.
Hepatopancreaticobiliary Surgery
The study by Breitenstein et al. [18] was the only included publication focusing on hepatectomy. Based on the outcomes of 615 patients undergoing liver resection in a Swiss hospital, Breitenstein et al. identified four independent risk factors in their prospective study, allowing early identification of patients at high risk of complications. They also found that patients with moderate to severe complications (Grades III-V according to the Clavien-Dindo classification [5, 17] Table 2) .
The remaining 14 publications discussed pancreatic resection [19-24, 33, 34, 37-42] . Only four of these studies had a prospective design [20, 21, 33, 34] . Clinical and economic data sources are listed in Table 1 and were single-hospital data, with the exception of Fuks et al. [39] who collected data from five hospitals, and Simons et al. [42] who used a large national database. classical PD, DP with stapler, DP hand-sewn Pancreatic fistula/Grade A fistulae were not included.
Grade B and C fistula grading was verified using a webbased calculator [69] ; latent fistulae were defined according to Pratt et al. [21] ; other complications were classified according to Dindo et al. [5] Data from a single hospital/NA (Germany) Six of these studies [19, 21, 24, 38, 39, 41] focused on the complication of postoperative pancreatic fistulae (POPF), which were graded using the International Study Group of Pancreatic Fistula (ISGPF) system [43] (except in Haddad et al. [41] , where no grading system is reported). Belyaev et al. [38] and Vanounou et al. [24] both also reported other complications, which were graded using the Clavien-Dindo classification [5, 17] . The identification of risk factors is a main objective in four of these studies [19, 38, 39, 41] , whereas Pratt et al. [21] investigated the importance of latent fistulae, and Vanounou et al. [24] evaluated the benefits of prophylactic octreotide. Overall, these studies showed that POPF lead to increased hospital LOS, increased resource use (e.g. re-operations, emergency visits, intensive care, antibiotics, supplemental nutrition, percutaneous drainage and re-admissions) and increased cost (estimates for additional cost ranging from US$5,986 [$6,788] to US$94,830 [$113,206] , or up to five times the cost for patients without POPF), which is dependent on the severity of POPF.
Topal et al. [23] analysed hospital costs and included other complications as well as POPF. POPF were again graded according to the ISGPF system, and the ClavienDindo system [5, 17] was used to grade all other complications. LOS and octreotide administrations were reported, both of which were increased in line with the data reported above for the dedicated POPF studies. Non-POPF and POPF complications added an estimated €2,828 ($4,479) and €6,660 ($10,550), respectively, per patient ( Table 2 ).
All complications (not pre-specified) were included in three analyses [20, 33, 42] . Only Simons et al. [42] did not use the Clavien-Dindo classification [5, 17] , but used the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Casadei et al. [33] evaluated the Clavien-Dindo classification [5, 17] , concluding that it is a simple and valuable tool in pancreatic surgery. Simons et al. [42] analysed US national complication rates, which were found to have changed very little between 1998 and 2006. Kent et al. [20] studied the economic impact of re-admission. Overall, the conclusions on LOS, other resource use (re-operations, re-admissions and time to catheter removal) and cost were in agreement with those discussed above ( Table 2) .
In two publications on pancreatic leaks [22, 34] no severity grading system was used. Jimenez et al. [34] evaluated a new surgical method, whereas Rodriguez et al. [22] evaluated the economic impact of leaks. Both analyses agree that complications are costly (an estimated increase of 122 %, or US$14,179 ($18,034) [22] ), increasing LOS and resource use ( Table 2) .
Neither the publication on intra-abdominal sepsis (IAS) [37] nor that on secondary surgery [40] reported the use of a severity grading system. The publications do not Where only one data source is listed, this was used for both clinical and economic purposes Unless specifically reported in the study, the increased LOS and cost per patient with complications has been calculated by subtracting the LOS/cost/resource use for the non-complicated group from the LOS/cost/resource use in the complicated group. If such a calculation is possible in multiple studies (e.g. postoperative pancreatic fistula), a range (minimum-maximum) across studies has been reported b Calculated from Varela et al. [31] ; €39,437.39 total excess cost for whole cohort of n = 21, mean cost per patient = €1,878
c Please see Sect. 2 for details of the conversion method used comment on cost but report increased LOS and other resource use (drains, octreotide, additional surgery) for patients with complications (compared with those without such complications; Table 2 ). Four publications report costs of POPF (see Table 2 ). Costs vary considerably between studies, with a common trend towards higher cost with increased severity of POPF ( Fig. 2; both Vanounou et al. [24] and Pratt et al. [21] use US data, whereas Daskalaki et al. [19] is an Italian study and Topal et al. [23] is a Belgian study).
Urologic Surgery
All complications [11] , bacteriuria [44] , rectal injury [45] and lymphoceles [46] were analysed. No severity grading was reported in any of these publications and all employed a retrospective study design (Table 1) . Data sources were a large national database [11] , single hospitals [44, 45] and not reported [46] (Table 1) . Only one publication reported costs, which were increased for patients with complications (by US$3,034 ($3,485) [or 60 %] to US$8,005 ($9,196) [11] ) and none of the papers contained data on hospital LOS. Other resource use (time with catheter, drains, additional surgery) was reported in three publications [44] [45] [46] , all of which reported higher resource use for patients with complications (Table 2) . Few publications were available, which furthermore contained little data on the economic impact of surgical complications. It therefore appears that the field of urologic surgery is especially in need of standardised complications research. 
Gynaecology
All six publications focused on hysterectomy [25-28, 47, 48] , with two also including Caesarean sections [25, 26] . The majority of studies used a database as source data, with only one relying on data from a single hospital [48] . None of the studies was prospective ( Table 1 ). The complications discussed were non-infectious urethral catheter-related complications [47] , any infection [27, 28] , vesicovaginal fistula [48] , and SSI [25, 26] . No complication severity grading was used in any of the publications, although ICD-9-CM codes were used for the identification of complications in three cases [26, 28, 47] , underlying bladder injuries were graded with the American Association for the Surgery of Trauma (AAST) system by Duong et al. [48] and SSIs were classified by type by Coello et al. [25] (Table 1 Table 2 ], although no correlation to the severity of the complications can be deduced.
Apart from POPF, reported above, SSI is the only complication for which costs are reported in more than one publication. Coello et al. [25] (UK data) focus on gynaecological procedures only, whereas de Lissovoy et al. [26] (US data) also report on other procedures (see Fig. 3 ). Similar to the POPF cost data, there is a large variation in the cost of complications between publications, countries and procedures (Fig. 3) .
Thoracic Surgery
All 13 thoracic surgery studies focused on pulmonary resection and had collected data from a single hospital (Table 1) [10, 29-31, 35, 36, 49-55] . With a single exception [36] , study design was retrospective throughout. Four analyses included all complications [10, 29, 35, 52] : Ghosh et al. [52] and Pilling et al. [29] evaluated the effectiveness of high dependency units (HDUs) and ICUs, respectively; HDUs were considered beneficial, whereas Pilling et al. were not convinced of the universal benefit of salvage ICU stays for certain patient groups. These papers did not report any complication severity grading. Seely et al. [35] evaluated the Clavien-Dindo classification [5, 17] for thoracic surgery, concluding that it is a feasible and valuable tool for surgical quality assessment. These publications consistently reported increased LOS and cost (additional US$12,400 ($16,896) [or 170 %] for patients dying in ICUs vs. those surviving [29] , up to US$33,158 ($38,337) (or an additional 150 %) for any complication [10] ) for patients with complications (compared with those without such complications) [ Table 2 ]. No other resource use data were reported.
Patients with (prolonged) air leaks/pneumothorax were the subject of six publications [31, 36, 49, 50, 54, 55] . The identification of risk factors was a main objective in three cases [36, 54, 55] , whereas Antanavicius et al. [49] compared suction with water seal, and Varela et al. [31] estimated hospital costs of air leaks. Bardell and Petsikas [50] reviewed reasons for prolonged hospital stay. None of these publications reported any complication classification. The publications agree on the increase of LOS, other resource use (chest tube duration, pleurodesis, wedge resection, re-admissions) and costs (additional €1,878 [$3,096] per patient with prolonged air leak [31] ) due to air leaks ( Table 2) .
Dulu et al. [51] reviewed prevalence and mortality associated with acute lung injury and acute respiratory distress syndrome. They report no classification of complications, and an increase in LOS and re-admissions (Tables 1 and 2) .
Ishikawa et al. [53] use the Acute Kidney Injury Network (AKIN) classification for acute kidney injury (AKI) in their study on incidence and risk factors for AKI following pulmonary resection. The economic analysis of atrial fibrillation and its relation to other complications by Roselli et al. [30] reports no complication classification. In these studies, LOS, other resource use (operating time and blood products) and cost (estimated 1.8 times cost increase for complications [30] ) are increased.
Discussion
We identified 38 publications evaluating cost and/or resource use associated with pancreatic, urologic, gynaecological, thoracic or hepatectomy surgical procedures. There was considerable heterogeneity between studies with regard to patient populations, outcomes and procedures, often precluding comparisons even between studies of the same procedure. Quantitative analysis or graphical presentation of the majority of the data was therefore not possible.
The most important issue in economic analyses of cost/ resource use of surgical complications, based on our systematic review, is the lack of consistency and transparency of recording and reporting of costs and resources used ( Table 2) . Cost data are reported in less than half of the included studies, ranging from detailed [19] to very limited [52] . Sensitivity analyses, demonstrating the robustness of results, were only performed in two studies [11, 24] . The majority of studies are also likely to have underestimated the economic burden of complications, as only LOS of the initial hospital stay, but not re-admissions, were considered. Re-admissions, however, are being increasingly recognised as a marker of quality of patient care [56] . This general heterogeneity between the studies in terms of patient populations and outcomes, as well as lack of consistency and transparency in the reporting of costs and resource use in major surgical complications studies, is a major challenge in the already complex economic evaluation of surgical procedures and devices [57] .
Although the importance of complication severity grading systems for the evaluation of costs and resource use appears to have been recognised in some areas of surgery (e.g. hepatopancreaticobiliary surgery), they are overall rarely used. Where complications were graded, the systems used were generally consistent across the studies, with the Clavien-Dindo and ISGPF systems being most popular. It has to be taken into account that only publications published after 2006 could have used these grading systems, which were first published in 2004 and 2005, respectively [5, 43] . This may explain the lack of classification systems in the thoracic surgery sector, where 8 of the 13 identified publications were published in or before 2005. However, in the other surgical sectors the majority of studies could have used a grading system. The general heterogeneity across the included studies, concerning all aspects considered (type of surgery, patient populations, outcomes recorded, cost/resource use recorded, source of cost/resource use, etc.) adds weight to the overall study results. There can be little doubt that (i) comparing the costs for patients with and without complications shows that complications represent an important economic burden for health care providers; (ii) costs increase with the severity of the complication and differ by type of complication; and (iii) the cost increase caused by surgical complications appears to be primarily the result of an increase in LOS.
With regard to the different surgical sectors included, we note that hepatopancreaticobiliary procedures have not only been most frequently evaluated but the available data are also fairly consistent and reliable due to the frequent use of the ISGPF [19, 21, 23, 24, 38, 39] and the ClavienDindo [18, 20, 23, 24, 33, 38] systems to grade complications. No other grading systems were used. Although 15 publications were identified for this surgical field, data were generally collected from a single hospital. Singlehospital data are more likely to allow the investigators to collect comprehensive, specific, relevant data, even allowing for prospective trial design, although the sample size is invariably limited. Of the 15 hepatopancreaticobiliary studies, five used a prospective design compared with only one prospective design among the remaining 23 included studies. Thoracic and urologic surgery evaluations (13 publications) were also based on single-hospital data. However, unlike for hepatopancreaticobiliary surgery, the methods used in the publications were inconsistent, with only two publications reporting the use of any adverse event grading system. Furthermore, few authors took full advantage of the single-hospital data source, with most utilising only limited cost/resource data. Five of the six studies on gynaecological procedures were based on databases, which provide a large sample for analysis. However, the data are necessarily limited with regard to the recorded items and a prospective study design is generally not possible. None of the gynaecological surgery publications used a severity grading system.
It may be considered a limitation of our systematic review that only certain types of surgery were considered and that our searches included analyses with very different objectives, which is reflected in the methods. Sources of grey literature were not searched and no other hand searches were performed. Not all major surgical segments (e.g. colorectal surgery) and all procedures (e.g. gynaecological myomectomy or gall bladder removal) could be included because of the volume of publications. However, there is no reason to believe that inclusion of these data would have had a significant impact on our results. No quality assessment was performed on the included publications. Our search strategy was not limited to RCTs, also including economic models or analyses, observational studies and cost/burden studies, making it difficult to apply a single quality assessment tool. No appropriately robust tools to perform quality assessment for the designs of included studies were available. Also, given the limited possibility of between-study comparisons and subsequent meta-analysis, it was deemed more appropriate to include all of the available evidence in order to provide an overview of the variety of evidence (i.e. different study designs) and highlight the available evidence relating to health care policy in our discussion. A comparison of the incidence and cost of complications between different types of surgery would certainly be of interest, and should be addressed by dedicated research.
Our systematic review has confirmed the outcomes of most individual cost studies, namely that complication rates in surgery are still high and that complications are costly to payers, costs increasing with complication severity. Health care providers are already implementing a variety of strategies in order to reduce costs associated with surgery in general [58] [59] [60] [61] or associated with specific procedures [62] . However, for health care providers, more accurate recording of surgical complications and their severity is required in order to identify the areas where investment in interventions is most required to decrease complication incidence, improve patient outcomes and to reduce costs. Accurate clinical and economic input data are also essential for economic evaluations of surgical devices/ pharmaceuticals, which in turn will also help health care providers to allocate their resources cost effectively. However, there is little formalised guidance, either on the methods to be used when conducting and reporting cost/ resource use studies in surgery, or on the prospective collection of such data in device clinical trials. One way this is currently already addressed is by the American College of Surgeons National Surgical Quality Improvement Program, which offers member hospitals around the world specific, targeted collection of data relating to surgical complications [63] . Beyond data collection, the programme offers members a package of quality support tools with the aim of increasing surgical quality and reducing complication rates. A study of 118 participating hospitals [64] showed that 66 % of hospitals improved risk-adjusted mortality (mean observed/expected improvement 0.174; p \ 0.05) and 82 % improved risk adjusted complication rates (mean improvement 0.114; p \ 0.05). There are also other similar but smaller programmes, such as the Tennessee Surgical Quality Collaborative [65] ; their outcomes are also promising, with observed reductions in complication rates and costs, although not in mortality [66] .
Hospital reimbursement systems are often based on reference costs, with specific procedures being associated with predefined reimbursement amounts (e.g. in the UK and the US). For procedures with complications, hospitals are reimbursed more than for uncomplicated procedures. While this is clearly necessary in order to cover costs, it can lead to situations where hospitals draw a financial profit from complications, as illustrated in recent publications by Eappen et al. [67] and Krupka et al. [68] . Under such circumstances, hospitals may have to work with payers to implement strategies to reduce complication rates, which may initially be costly [68] . Policy makers should also take such business considerations into account.
Conclusion
The cost of surgical complications is high, dependent on the type of complication, complication severity, and driven primarily by LOS. Our results show considerable heterogeneity between studies with regard to patient populations, outcomes and procedures and lack of consistency and transparency of recording and reporting of costs and resources used. Consistent and accurate collection of data on complications is required in order to inform goodquality economic analyses. Reliable economic data on surgical complications will help hospitals to identify areas where investment is required and to take evidence-based decisions on cost-effective resource allocation.
